These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 11953170

  • 1. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J, Jia R, Bao Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 25; 8(3):118-26. PubMed ID: 17907099
    [Abstract] [Full Text] [Related]

  • 3. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB, Zhang L, Yang LY.
    Ren Fail; 2012 Sep 25; 34(1):83-7. PubMed ID: 22011322
    [Abstract] [Full Text] [Related]

  • 4. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
    Zhang YW, Xie D, Chen YX, Zhang HY, Xia ZX.
    Exp Clin Endocrinol Diabetes; 2006 Nov 20; 114(10):563-8. PubMed ID: 17177138
    [Abstract] [Full Text] [Related]

  • 6. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M, Zhang Y, Miao Y, Li L, Gong HP, Ma X, Sun H, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):232-6. PubMed ID: 16677501
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S, Dontamalla SK, Mondru AK, Sannigrahi S, Veerareddy PR.
    Biol Trace Elem Res; 2011 Jan 24; 139(1):55-71. PubMed ID: 20174975
    [Abstract] [Full Text] [Related]

  • 8. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].
    Kong WX, Ma J, Gu Y, Yang HC, Zuo YQ, Lin SY.
    Zhonghua Nei Ke Za Zhi; 2003 Mar 24; 42(3):186-90. PubMed ID: 12816702
    [Abstract] [Full Text] [Related]

  • 9. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.
    Acta Histochem; 2002 Mar 24; 104(2):123-30. PubMed ID: 12086332
    [Abstract] [Full Text] [Related]

  • 10. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Mar 24; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 11. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
    Komers R, Tian W, Lindsley JN, Oyama TT, Cohen DM, Anderson S.
    J Lab Clin Med; 2002 Nov 24; 140(5):351-7. PubMed ID: 12434137
    [Abstract] [Full Text] [Related]

  • 12. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 24; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM, del Re E, Brown D, Lin HY.
    Diabetes; 2007 Feb 24; 56(2):380-8. PubMed ID: 17259382
    [Abstract] [Full Text] [Related]

  • 14. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
    Guo H, Gan L, Yu Z.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 10; 81(21):1327-9. PubMed ID: 16200729
    [Abstract] [Full Text] [Related]

  • 15. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T, Pawlik M, Konturek SJ, Pawlik WW, Hahn EG.
    J Physiol Pharmacol; 2004 Dec 10; 55(4):773-90. PubMed ID: 15613743
    [Abstract] [Full Text] [Related]

  • 16. [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys].
    Xiao HQ, Shi W, Zhang Y, Liang YZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr 10; 29(4):671-5. PubMed ID: 19403392
    [Abstract] [Full Text] [Related]

  • 17. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z, Chen CX.
    Phytomedicine; 2013 Aug 15; 20(11):1023-9. PubMed ID: 23746755
    [Abstract] [Full Text] [Related]

  • 18. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
    Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT.
    Horm Metab Res; 2006 Feb 15; 38(2):82-8. PubMed ID: 16523407
    [Abstract] [Full Text] [Related]

  • 19. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway.
    González E, Roselló-Catafau J, Jawerbaum A, Vela J, Sinner D, Pustovrh C, White V, Xaus C, Peralta C, Gimeno MA.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun 15; 64(6):311-6. PubMed ID: 11427040
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
    Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SL.
    J Hepatol; 2004 Aug 15; 41(2):251-8. PubMed ID: 15288474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.